FibroBiologics Clinical Update
Tuesday, June 04, 2024
Regenerative Medicine
Company Presentation Theater 3
Based in Houston, FibroBiologics is a cell therapy, regenerative medicine company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 150+ US and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy.
Company Website:
http://www.fibrobiologics.com
Lead Product in Development:
Multiple Sclerosis and Wound Care
Number Of Unlicensed Products (For Which You Are Seeking Partners):
6
Exchange
Nasdaq Global Exchange
Ticker
FBLG
Company HQ City
Houston
Company HQ State
Texas
Company HQ Country
United States
CEO/Top Company Official
Pete OHeeron
Development Phase of Primary Product
Phase I
Primary Speaker
)
)
)
)
)
)
){kind=logo}
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())